About: Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2001 (uk) im September 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2001 (ast) scientific article published on 01 September 2001 (en)
publication date	wds:Q74458988-0018F1CF-84F7-4AB8-885F-AB699817C5A2
publication date	2001-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74458988-5B28C319-87AE-4534-A127-DC84D40B5232
language of work or name	English
cites work	wds:Q74458988-19AE476D-EAA7-4621-A11F-BEE142D07EDB wds:Q74458988-333E384B-0A88-45ED-A446-6DEE3364FAE8 wds:Q74458988-43883A18-C9BC-4547-90B6-977AA8D17B5C wds:Q74458988-6B192EA1-DC0C-4D7A-8968-89AFE5F48601 wds:Q74458988-753311D5-92B9-41C6-A72A-6E3079A27189 wds:Q74458988-910AD4F3-B6C9-4046-9F42-CFCCD630565F wds:Q74458988-9A4435EC-BE89-4214-BD92-901C7F5D4085 wds:Q74458988-B24FC6AC-5AD2-4842-BE91-35FEE73B617F wds:Q74458988-C74BAF7B-49D7-430B-95FB-F394F9606B3D wds:Q74458988-C9A36F59-58B9-48E1-A88C-ABB3893DEA08 wds:Q74458988-CAA22373-1AF0-458A-B4B0-9A1C287CCC4F wds:Q74458988-DBB20E43-936F-40C4-95FC-7426B0E7E689
cites work	Over a decade of experience with a yeast recombinant hepatitis B vaccine Are booster immunisations needed for lifelong hepatitis B immunity? Compliance of hepatitis B vaccination in patients presenting to a teenage clinic Development and clinical application of new polyvalent combined paediatric vaccines Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine The first combined vaccine against hepatitis A and B: an overview A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years Assessment of a universal, school-based hepatitis B vaccination program Vaccination campaign against hepatitis B for 12-year-old subjects in Italy Randomised controlled trial of an educational strategy to increase school-based adolescent hepatitis B vaccination Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity
author name string	wds:Q74458988-74E38704-3FF6-4DD9-961B-BEA11C69295F wds:Q74458988-7796C3E8-271E-4661-9D8E-EA2E45B80571 wds:Q74458988-BE2C0624-F54D-4F48-AE64-71BA89F03D53 wds:Q74458988-CA55A319-813A-46DB-92C9-D270A4616C12
author name string	M A Burgess A J Rodger F Collard S A Waite
rdfs:label	Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study (en) Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study (nl)
skos:prefLabel	Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study (en) Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study (nl)
name	Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study (en) Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study (nl)
title	wds:Q74458988-5546E3AB-BC4E-4559-AEA6-9E4E23C7FDBF
title	Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study (en)
page(s)	wds:Q74458988-605C53B1-8EE3-4BAC-92DE-1D2FA5913A9B
page(s)	4835-4841
instance of	wds:Q74458988-2EBFBF44-EDC6-4D1E-AAC0-E34CC6FFED57
instance of	scholarly article
main subject	wds:Q74458988-2E025DE1-0575-41C5-BE5A-BA70F3EF75C7
main subject	hepatitis A
PubMed ID	wds:Q74458988-7B0D2464-9E69-4180-AECD-198C6F553A15
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11535336
PubMed ID	11535336
published in	wds:Q74458988-31EA1650-44BE-4933-A47B-DCD932693A91
published in	Vaccine
issue	wds:Q74458988-9477E9AE-3FDB-452F-B390-7F2868BDBE48
volume	wds:Q74458988-89A4F1E3-3B2C-4C65-B08A-68F6183188A4
issue	32
volume	19
number of pages	wds:Q74458988-BD7E0119-927C-4708-873E-0BD95CFE7BD7
number of pages	7 (xsd:decimal)
DOI	wds:Q74458988-21CB3CFD-0298-4568-B997-A695A2191A26
DOI	http://dx.doi.org/10.1016/S0264-410X(01)00221-3
DOI	10.1016/S0264-410X(01)00221-3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74458988
is cites work of	Human immunity and the design of multi-component, single target vaccines A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children Hepatitis vaccines: recent advances The place of accelerated schedules for hepatitis A and B vaccinations Combined two-dose hepatitis A and B vaccine (AmBirix). Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Hepatitis A immunisation in persons not previously exposed to hepatitis A Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristics Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Prevention of Viral Hepatitis. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children Current awareness in pharmacoepidemiology and drug safety
is cites work of	wds:Q35200980-FC70DD8D-9E8C-4BFD-9145-01AFD9C86C2C wds:Q35874598-C3429B6A-387D-484B-82B5-847A4279BB14 wds:Q74267819-9BB45A2F-90A0-4004-8249-539763E15241 wds:Q35903676-26AA49C7-3158-4D40-96E4-AE4285D6F41A wds:Q40568074-BCFC3638-9AE9-4618-BD1A-BD75566AC59B wds:Q46770939-8BC24CCD-25F4-46E2-A5E3-B1FDCE353332 wds:Q35592389-496269A1-4607-45D0-97AF-C546A5B64A1C wds:Q84574899-0F9465DA-4287-4DC1-B316-BA9E21497CA9 wds:Q51055745-E5A48125-1A4A-4BEB-A0BC-09D7B102BECF wds:Q35742315-37226398-28B9-489E-936A-6EA5CF3CAFBC

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software